Related Experiment Videos
Asymmetric (deoxy dimer/azido-met dimer) hemoglobin hybrids dissociate within seconds.
1INSERM U473, 84 rue du Général Leclerc, Le Kremlin-Bicêtre Cedex, 94276, France.
Journal of Molecular Biology
|August 10, 1999
Summary
Asymmetric hemoglobin hybrids are unstable, dissociating within seconds, contradicting the symmetry rule. This study reveals their short lifetime, challenging previous stability findings.
Area of Science:
- Biochemistry
- Biophysics
- Protein dynamics
Background:
- Asymmetric hemoglobin (Hb) hybrids, composed of deoxy and liganded dimers, have been studied for their stability.
- Previous research suggested enhanced stability for doubly liganded hybrids, with dissociation times over 100 seconds.
Purpose of the Study:
- To investigate the stability and dissociation kinetics of asymmetric hemoglobin hybrids.
- To determine the lifetime of the [deoxy/azido-met] hybrid (species 21) and assess its stability relative to symmetric counterparts.
Main Methods:
- Utilized double mixing stopped-flow experiments to create and study asymmetric Hb hybrids.
- Generated [deoxy dimer/azido-met dimer] hybrids within 200 ms by mixing dithionite with oxyHb and azido-metHb solutions.
- Probed allosteric states by CO binding after variable aging times of the asymmetric hybrids.
Main Results:
- Freshly formed asymmetric hybrids exhibited rapid CO binding, characteristic of the R-state Hb.
- Aging of hybrids from 0.1 to 10 seconds increased the fraction of slow CO binding, indicating dissociation into deoxy Hb tetramers.
- Simulated tetramer to dimer dissociation rates for species 21 were approximately 1.5-1.9/second, similar to liganded Hb, not deoxy Hb.
Conclusions:
- The asymmetric [deoxy/azido-met] hybrid (species 21) has a short lifetime of about one second.
- These findings do not support the symmetry rule, which predicts enhanced stability for asymmetric Hb hybrids.
- The observed kinetics are inconsistent with a slow R to T transition, suggesting rapid dimer dissociation is the primary pathway.